Minimum 3 sessions per week
What can you expect when starting GLP-1s during perimenopause
In add-on therapy, starting with an SGLT2 inhibitor may be preferable, especially for patients with established diabetic kidney disease, owing to its well-documented benefits in reducing intraglomerular pressure and albuminuria
Key Benefits Enhance GLP-1 receptor activation and sustain its response with a combination of clinically studied prebiotics, probiotics, postbiotics, and fast-acting GLP-1 activators that work synergistically Control appetite by reducing cravings and stimulating satiety signals with hops extract, probiotic, and postbiotic* Promote digestive health and regularity with a prebiotic that promotes the growth of Akkermansia muciniphila for GLP-1 signaling Free from gluten, dairy, peanut, tree nut, fish, shellfish, soy, sesame, egg, active yeast, artificial flavors, colors, sweeteners, and unnecessary excipients